Heads up: some links below are affiliate links — assume any provider we list may compensate us, at no cost to you. It never buys a better score, but the providers we work with are listed first. See our affiliate disclosure.
Longevixx review
"Plans from $129/mo · confirmed after provider review" is the whole of the pricing: no drug breakdown, no dose breakdown, nothing fixed before an intake. The homepage contradicts itself on coverage within one screen — a ticker reading "50-state telehealth" beside a stat block reading "0 states telehealth access". And the headline result, "~15–20% avg. body-weight change", is sourced to clinical trials of compounded semaglutide and tirzepatide. Those trials do not exist.
- HSA / FSA-eligible
- Editor-vetted
- No insurance needed
Longevixx at a glance
- Semaglutide
- From $129/mo, not confirmed until after provider review
- Tirzepatide
- Not priced separately on the site
- Coverage
- Contradicted on its own homepage — "0 states" beside "50-state telehealth"
- Start
- Not published
How we scored Longevixx
Each factor is read off Longevixx's published pricing, disclosures and intake flow, and the six roll up into the 31/100 Rx-Readiness Score on the same weighted six-factor framework we apply to every provider — never nudged by whether a provider pays us.
One figure exists — "from $129/mo" — the site calls it an educational estimate, says it is confirmed only after provider review, and never breaks it down by drug or dose. Tirzepatide has a program page and no price.
Scored low because the site's own two answers contradict each other on one screen: a ticker reading "50-state telehealth" beside a stat block reading "0 states telehealth access", with the FAQ's state question left unanswered in the served HTML.
It separates its programs by molecule and by microdose rather than selling one undifferentiated plan, which is a point in its favor — but only semaglutide carries a figure, and that figure is a floor. No brand-name lane and no oral form.
Scored for non-disclosure. No refund policy and no cancellation terms appear anywhere on the site. "$0 if you're not approved" covers the decline case only, which is the one case where there is nothing to unwind.
Scored for non-disclosure. The process is described as a secure online assessment with "no clinic visit, no waiting room", which rules out an in-person appointment but not a video call, and nothing on the site addresses the difference.
Scored for non-disclosure. No review window, approval time or shipping estimate is published anywhere; the site says only that medication is shipped cold-chain.
How we verified this review
- Last verified
- August 2026
- Confidence
- low
- Primary source
- startlongevix.com
Read from Longevixx's own site in August 2026. The only published price is "Plans from $129/mo · confirmed after provider review", with no breakdown by drug or dose and no separate price for tirzepatide despite its own program page. The homepage contradicts itself on coverage, claiming "50-state telehealth" in one element and "0 states telehealth access" in another. Its headline "~15-20% avg. body-weight change" is attributed to clinical trials of compounded semaglutide and tirzepatide formulations; no such trials exist, and those figures come from studies of the branded drugs. No refund or cancellation policy appears anywhere on the site.
Pricing
Prices re-verified
| Medication | Monthly | Plan |
|---|---|---|
| Compounded semaglutideStarting price, not confirmed until after review"Plans from $129 /mo · confirmed after provider review", described by the site as an "educational estimate only". | $129 | Starting price, not confirmed until after review"Plans from $129 /mo · confirmed after provider review", described by the site as an "educational estimate only". |
HSA/FSA generally applies to GLP-1 telehealth; confirm with your plan. These figures are Longevixx's public disclosures at last review and change often; confirm the current number on Longevixx's own site.
What we like
- "$0 if you're not approved" is stated plainly and repeatedly
- Separates its programs by molecule and by microdose rather than selling one undifferentiated plan
- Says medication is compounded in the USA and shipped cold-chain, and carries the not-FDA-approved disclosure
The caveats
- The "~15–20% avg. body-weight change" claim is attributed to clinical trials of compounded semaglutide and tirzepatide — no such trials exist; those results belong to studies of the branded drugs
- The only published price is "from $129/mo", confirmed after provider review
- Tirzepatide has its own program page but no price of its own
- The homepage claims "50-state telehealth" in a ticker while its stat block reads "0 states telehealth access"
- No refund policy and no cancellation terms appear anywhere on the site
- The registered address is a mailbox-style suite number rather than a clinic or office
- Three of its patient testimonials appear word for word, names and durations intact, on LunaRx — a different company with a different LLC in a different state
- Its FAQ asks "What states is this service available in?" and the answer is not present in the page's HTML at all — the question renders, the answer does not
Longevixx for working moms: our verdict
"Plans from $129/mo · confirmed after provider review" is the whole of the pricing: no drug breakdown, no dose breakdown, nothing fixed before an intake. The homepage contradicts itself on coverage within one screen — a ticker reading "50-state telehealth" beside a stat block reading "0 states telehealth access". And the headline result, "~15–20% avg. body-weight change", is sourced to clinical trials of compounded semaglutide and tirzepatide. Those trials do not exist. It runs about $129/month — toward the affordable end of what we track.
We weigh Longevixx the way working moms actually have to: not just the monthly line on your budget, but how fast you can start without a scheduled video visit and a flat monthly price that doesn't climb as your dose does — the parts a generic review does not measure.
What Longevixx will cost you
- Compounded semaglutide — Starting price, not confirmed until after review: $129/mo
That sits below the roughly $179 median ongoing price across the providers we track for working moms — a real cost advantage.
The medications Longevixx prescribes
Longevixx prescribes semaglutide (the active drug in Wegovy and Ozempic). These are compounded formulations from a licensed pharmacy — the reason the price stays down — but compounded GLP-1s aren't FDA-approved finished products the way Wegovy and Zepbound are.
Where Longevixx fits — and where it doesn't — for working moms
Right for you if…
- the monthly line on your budget is a real barrier and you want a low, predictable number.
Not your best option if…
- you specifically want an FDA-approved brand pen and insurance navigation.
- you want frictionless cancellation and no prepay lock-in — the exit terms are the weak point here.
- you'd rather the most predictable place to start and pause — which is exactly what our #1 pick, CoreAge Rx, is designed around.
Trust, safety, and the fine print
Our confidence here is limited — Longevixx publishes little about how its program actually runs, so you're buying on price and trust in its partners. As with any compounded GLP-1, the most useful thing working moms can do is confirm which licensed pharmacy fills the prescription and what's in the formulation — we explain how we weigh oversight in our scoring methodology.
A standing caveat for working moms: GLP-1 medications aren't established as safe during pregnancy or breastfeeding, and every label advises against use. Nothing here changes that — plan the timing with your own clinician.
The bottom line
Longevixx is a genuine value play — weigh it on how fast you can start without a scheduled video visit and a flat monthly price that doesn't climb as your dose does against the alternatives below. For most working moms, CoreAge Rx remains the stronger all-round fit — see why it tops our ranking.
The bottom line for working moms
Best for: Difficult to specify, because the site settles almost nothing before you submit a medical history.
Alternatives to Longevixx
Providers we have a referral relationship with, ordered by Rx-Readiness Score — highest first. A fee never moves a score, but it does decide who appears here, so this is not the full list: see the complete ranking.
- Visit CoreAge RxRx-Readiness95100CoreAge RxOur #1 pick
The shortlist pick: one flat price that doesn't climb as your dose does, both molecules on a single plan, and a nationwide async intake you can finish on a break.
- Visit Pallas HealthRx-Readiness89100
Pallas Health removes the two things that usually cost a working parent the most time: it publishes every price before intake, and it runs care asynchronously in 43 of 50 states, so there's no video appointment to wedge into a workday. Compounded semaglutide averages about $199 a month and tirzepatide $299, and unusually the genuine FDA-approved pens sit alongside them — Zepbound $1,069, Ozempic $1,299, Wegovy and Mounjaro $1,349 — all cash-pay from the same clinician. The price is flat at every dose, so a titration never produces a surprise bill, and the plan figure already contains the clinician, dose adjustments, check-ins and messaging with no membership fee. Its cancellation terms are unusually concrete: cancel free through the portal, keep access to the end of the paid period, full refund if a clinician declines you, and a $5 processing fee on a qualifying refund. The trade-offs are that billing lands every 12 weeks in $597 and $897 blocks rather than monthly, the compounding pharmacy is never named, and insurance is never billed.
- Visit Trimi HealthRx-Readiness88100
The price-first partner: some of the lowest flat, all-inclusive compounded pricing we track, nationwide and async — strong if the monthly number is your deciding factor and you read the annual-prepay fine print.
Keep comparing Longevixx
Head-to-head & alternatives
Longevixx, answered
- What does Longevixx cost?
- One sentence is the whole of it: "Plans from $129/mo · confirmed after provider review", read live on 2026-08-26 and described by the site itself as an educational estimate only. There is no breakdown by drug, no breakdown by dose, and tirzepatide has its own program page with no price of its own. Nothing about what you will pay is settled before you submit a medical history.
- Is the 15 to 20 percent weight-loss figure real?
- The number is real; the sourcing is not. Longevixx attributes "~15–20% avg. body-weight change" to clinical trials of compounded semaglutide and tirzepatide. No such trials exist. Compounded preparations are not FDA-approved and never go through registrational trials — those results come from studies of the branded drugs, which are a different product made under different controls. This is the single most important thing to know before reading anything else on the page.
- Which states does it serve?
- Its homepage answers this twice, and the two answers contradict each other within one screen: a scrolling ticker reads "50-state telehealth" while a statistics block reads "0 states telehealth access". The FAQ then asks "What states is this service available in?" and, in the HTML we received on 2026-08-26, supplies no answer at all. Three attempts, no usable information.
- What happens if I am not approved?
- Nothing is charged. "$0 if you're not approved" is stated plainly and repeatedly across the page, which is a genuine point in its favor — an assessment that ends in a decline should not cost you. What is not stated anywhere is what happens after you ARE approved: no refund policy and no cancellation terms appear on the site.
- Who is behind Longevixx?
- Longevixx LLC, named in its own footer, at a registered address that is a mailbox-style suite number rather than a clinic or an office. We screened the entity, the brand name and the domain root against the FDA warning-letter index and all three came back clean. It also carries the correct disclosure that compounded medications are not FDA-approved, and says its medication is compounded in the USA and shipped cold-chain.
- Why do its patient stories look familiar?
- Because three of them are not unique to Longevixx. Jessica R. at seven months on semaglutide, Michael T. at six and Sarah M. at nine appear word for word — same names, same durations, same drug — on LunaRx, a separate company with its own LLC in a different state, where they are also presented as that company's own patients. Whichever site you found first, the testimonials are not evidence about it.
Pricing, states and verification reflect Longevixx's public disclosures at last review; the Rx-Readiness Score is our editorial judgment per the published methodology. This is background reading, not medical advice — GLP-1 medications are not established as safe in pregnancy or breastfeeding. See our medical disclaimer and how we're funded.